标题
Emerging trends in immunotherapy for pediatric sarcomas
作者
关键词
Immunotherapy, Pediatric sarcoma, Osteosarcoma, Ewing’s sarcoma, Rhabdomyosarcoma, Cancer vaccines, Adoptive cellular therapy, CAR T cell therapy, Checkpoint blockade
出版物
Journal of Hematology & Oncology
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-07-16
DOI
10.1186/s13045-019-0756-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
- (2019) Moshe Sade-Feldman et al. CELL
- CD248: A therapeutic target in cancer and fibrotic diseases
- (2019) Beverly A. Teicher Oncotarget
- MicroRNA-140 suppresses osteosarcoma tumor growth by enhancing anti-tumor immune response and blocking mTOR signaling
- (2018) Xianglu Ji et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PD-L1 assessment in pediatric rhabdomyosarcoma: a pilot study
- (2018) Giulia Bertolini et al. BMC CANCER
- Magnetic Resonance Imaging of Tumor-Associated Macrophages: Clinical Translation
- (2018) Maryam Aghighi et al. CLINICAL CANCER RESEARCH
- Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma
- (2018) Y. Guo et al. EUROPEAN JOURNAL OF CANCER
- PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression
- (2018) Haidong Tang et al. JOURNAL OF CLINICAL INVESTIGATION
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials
- (2018) Sandra P D'Angelo et al. LANCET ONCOLOGY
- Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
- (2018) Christopher W. Mount et al. NATURE MEDICINE
- A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer
- (2018) Gordana Vlahovic et al. ONCOLOGIST
- Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors?
- (2018) Monica Mangoni et al. Radiologia Medica
- T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-G
- (2018) Christian Spurny et al. Oncotarget
- CD99 at the crossroads of physiology and pathology
- (2018) Michela Pasello et al. Journal of Cell Communication and Signaling
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment
- (2018) Nicholas L. Denton et al. Molecular Therapy-Oncolytics
- Pretreatment Neutrophil-to-Lymphocyte Ratio and Lymphocyte Recovery
- (2017) Liliana Vasquez et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
- (2017) Hussein A Tawbi et al. LANCET ONCOLOGY
- Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2
- (2017) Cristina Meazza et al. MEDICAL ONCOLOGY
- Programmed cell death ligand 1 (PD-L1) expression is not a predominant feature in Ewing sarcomas
- (2017) Christian Spurny et al. PEDIATRIC BLOOD & CANCER
- Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children
- (2017) Michael Merker et al. Oncotarget
- Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
- (2017) Nicola Mitwasi et al. Oncotarget
- Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors
- (2017) Kristy Pilbeam et al. Oncotarget
- The neoepitope landscape in pediatric cancers
- (2017) Ti-Cheng Chang et al. Genome Medicine
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Identification and editing of stem-like cells in methylcholanthrene-induced sarcomas
- (2017) Emilie T.E Gross et al. OncoImmunology
- Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade
- (2017) Chipman RG Stroud et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- A Comparison of Pediatric vs. Adult Patients with the Ewing Sarcoma Family of Tumors
- (2017) Vivek Verma et al. Frontiers in Oncology
- The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma
- (2017) Marie-Françoise Heymann et al. CELLULAR IMMUNOLOGY
- RANK-RANKL signalling in cancer
- (2016) N. Renema et al. BIOSCIENCE REPORTS
- Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus
- (2016) Matt L. Harlow et al. CANCER RESEARCH
- Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma
- (2016) N. J. Mason et al. CLINICAL CANCER RESEARCH
- Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor
- (2016) Christy L. Osgood et al. CLINICAL CANCER RESEARCH
- Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas
- (2016) M. S. Merchant et al. CLINICAL CANCER RESEARCH
- Three-year Follow up of GMCSF/bi-shRNA furin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma
- (2016) Maurizio Ghisoli et al. MOLECULAR THERAPY
- Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults
- (2016) Konstantin Dobrenkov et al. PEDIATRIC BLOOD & CANCER
- Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G
- (2016) Sareetha Kailayangiri et al. OncoImmunology
- Mesenchymal Stem/Stromal Cells under Stress Increase Osteosarcoma Migration and Apoptosis Resistance via Extracellular Vesicle Mediated Communication
- (2016) Krishna C. Vallabhaneni et al. PLoS One
- Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
- (2016) Pratistha Koirala et al. Scientific Reports
- A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma
- (2015) Deepa K. Krishnadas et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines
- (2015) J. M. Goldberg et al. CLINICAL CANCER RESEARCH
- Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors
- (2015) M. S. Merchant et al. CLINICAL CANCER RESEARCH
- Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
- (2015) Nabil Ahmed et al. JOURNAL OF CLINICAL ONCOLOGY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- CD8+/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study
- (2015) Benedikt Fritzsching et al. OncoImmunology
- Remarkable regression of a lung recurrence from an undifferentiated embryonal sarcoma of the liver treated with a DC vaccine combined with immune cells: A case report
- (2014) Shangyun Xie et al. CELLULAR IMMUNOLOGY
- Reversible LSD1 Inhibition Interferes with Global EWS/ETS Transcriptional Activity and Impedes Ewing Sarcoma Tumor Growth
- (2014) S. Sankar et al. CLINICAL CANCER RESEARCH
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Genomic Landscape of Pediatric Ewing Sarcoma
- (2014) B. D. Crompton et al. Cancer Discovery
- Targeting the DNA Repair Pathway in Ewing Sarcoma
- (2014) Elizabeth Stewart et al. Cell Reports
- Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma
- (2013) Michael Roth et al. CANCER
- Characterization of Ewing sarcoma associated cancer/testis antigens
- (2013) Dorothea E. Mahlendorf et al. CANCER BIOLOGY & THERAPY
- Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma
- (2012) Nourredine Himoudi et al. Clinical & Translational Oncology
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- Characteristics of human Ewing/PNET sarcoma models
- (2011) BeverlyA Teicher et al. ANNALS OF SAUDI MEDICINE
- Efficacy of Ganitumab (AMG 479), Alone and in Combination with Rapamycin, in Ewing's and Osteogenic Sarcoma Models
- (2011) P. J. Beltran et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer
- (2011) Neil Senzer et al. MOLECULAR THERAPY
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression
- (2009) Nabil Ahmed et al. MOLECULAR THERAPY
- A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma
- (2009) Hayriye V Erkizan et al. NATURE MEDICINE
- High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma
- (2008) Jacob A. Klapper et al. CANCER
- A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas
- (2008) C. L. Mackall et al. CLINICAL CANCER RESEARCH
- Engineered lentivector targeting of dendritic cells for in vivo immunization
- (2008) Lili Yang et al. NATURE BIOTECHNOLOGY
- Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors
- (2008) Aiko Suminoe et al. PEDIATRIC TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More